Association Between Circulating Endostatin, Hypertension Duration, and Hypertensive Target-Organ Damage
Association Between Circulating Endostatin, Hypertension Duration, and Hypertensive Target-Organ Damage
复制标题
DOI:
10.1161/hypertensionaha.113.02250
复制
发表时间:
2013-12-01
期刊:
影响因子:
8.3
通讯作者:
Arnlov, Johan
中科院分区:
文献类型:
--
作者:
Carlsson, Axel C.;Ruge, Toralph;Arnlov, Johan
Our aim is to study associations between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Long-term hypertension induces cardiovascular and renal remodeling. Circulating endostatin, a biologically active derivate of collagen XVIII, has been suggested to be a relevant marker for extracellular matrix turnover and remodeling in various diseases. However, the role of endostatin in hypertension and hypertensive target-organ damage is unclear. Serum endostatin was measured in 2 independent community-based cohorts: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; women 51%; n=812; mean age, 75 years) and the Uppsala Longitudinal Study of Adult Men (ULSAM; n=785; mean age, 77.6 years). Retrospective data on blood pressure measurements and antihypertensive medication (PIVUS >5 years, ULSAM >27 years), and cross-sectional data on echocardiographic left ventricular mass, endothelial function (endothelium-dependent vasodilation assessed by the invasive forearm model), and urinary albumin/creatinine ratio were available. In PIVUS, participants with 5 years of history of hypertension portrayed 0.42 SD (95% confidence interval, 0.23-0.61; P